Please assess the completion status of the following clinical trial:

Trial Title: Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Patients undergoing lung transplantation~Exclusion criteria:~* Participation in other experimental protocols

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Inhaled Nitric Oxide
- 2 (Type: PLACEBO_COMPARATOR): Placebo gas

Based on this trial design, predict the completion outcome and termination type (if applicable).